These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 969520)

  • 21. Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions.
    Micha JP; Goldstein BH; Birk CL; Rettenmaier MA; Brown JV
    Gynecol Oncol; 2006 Feb; 100(2):437-8. PubMed ID: 16226797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgery and endoxan therapy in ovarian carcinoma].
    Hennig R; Wagner KL; Korte W
    Arch Gynakol; 1971 Jun; 211(1):343-5. PubMed ID: 5108922
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adjuvant chemotherapy in ovarian carcinoma].
    Conte PF; Bruzzone M; Carnino F
    Minerva Ginecol; 1984 Apr; 36(4):191-4. PubMed ID: 6540425
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the prevention of postoperative recurrences in cancer of the ovaries].
    Mardakhiashvili ShI
    Vopr Onkol; 1968; 14(2):28-33. PubMed ID: 4300406
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of intervention surgery in stage III-IV epithelial ovarian carcinoma.
    Hoogland H; Blijham G; Bron H; Eekhout A; van Geuns H; Haest J; Huiskes H; Kornman J; de Koning Gans H; Lalisang F
    Prog Clin Biol Res; 1985; 201():213-5. PubMed ID: 3841592
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic trial of a combination of cytostatic agents in advanced ovarian carcinoma].
    Brandl K
    Zentralbl Gynakol; 1970 Feb; 92(8):233-9. PubMed ID: 5505972
    [No Abstract]   [Full Text] [Related]  

  • 27. [Paraneoplastic superior vena cava thrombosis disclosing an ovarian tumor].
    Padovani M; Tillie-Leblond I; Vennin P; Demarcq G; Wallaert B
    Rev Mal Respir; 1996 Dec; 13(6):598-600. PubMed ID: 9036506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
    Naumann R
    Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
    [No Abstract]   [Full Text] [Related]  

  • 29. Cisplatin-based chemotherapy in advanced ovarian cancer: initial experience in an Indian set-up.
    Charak BS; Agarwala S; Gopal R; Advani SH; Nadkarni KS; Pai VR; Saikia TK; Desai PB
    Indian J Cancer; 1989 Jun; 26(2):85-91. PubMed ID: 2592001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The treatment of ovarian carcinoma in the Univ.-Frauenklinik Tübingen since 1957 and its results].
    Pfleiderer A; Kiyan S
    Med Welt; 1967 Dec; 51():3095-102. PubMed ID: 5608859
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effective treatment of a patient with metastatic dysgerminoma of the ovary with endoxan (1 observation)].
    Aĭnbinder AM; Cheremnykh AA
    Vopr Onkol; 1967; 13(8):116-8. PubMed ID: 5601540
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of endoxan therapy on human chromosomes.
    Kawasaki M; Tojo S; Nishimura T; Doita Y; Sugahara T
    J Jpn Obstet Gynecol Soc; 1966 Apr; 13(2):103-8. PubMed ID: 6008633
    [No Abstract]   [Full Text] [Related]  

  • 33. Papillary thyroid carcinoma of struma ovarii.
    Griffiths AN; Jain B; Vine SJ
    J Obstet Gynaecol; 2004 Jan; 24(1):92-3. PubMed ID: 14675996
    [No Abstract]   [Full Text] [Related]  

  • 34. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary carcinoma in struma ovarii: an unusual presentation.
    Tomee JF; van der Heijden PF; van den Hout JH; Brinkhuis M; Veneman TF
    Neth J Med; 2008 Jun; 66(6):248-51. PubMed ID: 18689908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Our observations on the treatment of ovarian carcinoma with cytostatics].
    Krstalić V; Krstalić N
    Med Pregl; 1978; 31(11-12):521-2. PubMed ID: 739967
    [No Abstract]   [Full Text] [Related]  

  • 37. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
    Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
    Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bioenergetic metabolism in ovarian cancer treated with cyclophosphane in combination with hyperbaric oxygenation].
    Zel'vin BM; Vedernikova NV
    Vopr Onkol; 1979; 25(11):85-6. PubMed ID: 516573
    [No Abstract]   [Full Text] [Related]  

  • 39. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
    Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.